Concomitant Pulmonary Tuberculosis and Invasive Aspergillosis Infection in an Immunocompetent Host

  • Ashraf OE Ahmed Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar
  • Gawahir A. Ali Department of Infectious Diseases, Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar
  • Wael Goravey Department of Infectious Diseases, Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar

Keywords

Pulmonary tuberculosis, invasive aspergillosis, type II diabetes, immunocompromised

Abstract

Pulmonary tuberculosis (TB) is a common infection in developing countries and is associated with low socioeconomic status. It is considered a serious infection due it its long-term sequelae. Post-TB lung disease decreases life expectancy and increases the risk of recurrent TB infection. It also significantly increases the risk of other bacterial and fungal infections. Aspergillosis develops in the cavitary lesions of TB, worsening them and resulting in a deteriorating clinical situation. Concomitant pulmonary TB (PTB) and invasive aspergillosis is uncommon, particularly in the absence of factors that suppress the immune system. In this report, we describe the case of a healthy young adult without previous structural lung damage who presented with primary PTB and acute invasive aspergillosis infection, discuss the treatment dilemma and provide a literature review.

VIEW THE ENTIRE ARTICLE

References

  • Tsui J, Ho M, Lui G, Li T, Chen L, Iu L, et al. The clinical presentation and treatment outcomes of ocular tuberculosis: a 5-year experience in an endemic area. Int Ophthalmol 2021 Sep;41(9):3199–3209.
  • Sivasankari S, Senthamarai S, Anitha C, Sastry AS, Bhatt S, Kumudhavathi MS, et al. Prevalence of invasive aspergillosis among (PTB) patients in Kanchipuram, India. J Clin Diagn Res 2014 Mar;8(3):22–23.
  • Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 2003 Jul;16(3):463–496.
  • Loddenkemper R, Lipman M, Zumla A. Clinical aspects of adult tuberculosis. Cold Spring Harb Perspect Med 2016 Jan;6(1):a017848.
  • Pai M. Diagnosis of pulmonary tuberculosis: recent advances.J Indian Med Assoc 2013 May;111(5):332–336.
  • Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis 2017 Jan 15;64(2):111–115.
  • Attia EF, Pho Y, Nhem S, Sok C, By B, Phann D, et al. Tuberculosis and other bacterial co-infection in Cambodia: a single center retrospective cross-sectional study. BMC Pulm Med 2019 Mar 11;19(1):60.
  • Kindo AJ, Mathew R, Ravi A, Varadrajan M. Rare co-existence of Salmonella typhi and mycobacteria tuberculosis in a psoas abscess--a case report. Indian J Pathol Microbiol 2001 Oct;44(4):493–494.
  • Brook MG, Lucas RE, Pain AK. Clinical features and management of two cases of Streptococcus milleri chest infection. Scand J Infect Dis 1988;20(3):345–346.
  • Bansod S, Rai M. Emerging of mycotic infection in patients infected with Mycobacterium tuberculosis. World J Med Sci 2008 Jan 1;3(2):74–80.
  • Osman NM, Gomaa AA, Sayed NM, Abd el aziz AA. Microarray detection of fungal infection in pulmonary tuberculosis. Egypt J Chest Dis Tuberc 2013 Jan 1;62(1):151–157.
  • Guinea J, Torres-Narbona M, Gijón P, Muñoz P, Pozo F, Peláez T, et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 2010 Jul;16(7):870–877.
  • Amiri MRJ, Siami R, Khaledi A. Tuberculosis status and coinfection of pulmonary fungal infections in patients referred to reference laboratory of health centers Ghaemshahr City during 2007–2017. Ethiop J Health Sci 2018 Nov;28(6):683–690.
  • Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 2003 Oct 1;37(Suppl 3):S265–280.
  • Oladele RO, Irurhe NK, Foden P, Akanmu AS, Gbaja-Biamila T, Nwosu A, et al. Chronic pulmonary aspergillosis as a cause of smear-negative TB and/or TB treatment failure in Nigerians. Int J Tuberc Lung Dis 2017 Sep 1;21(9):1056–1061.
  • Buonomo AR, Viceconte G, Compare D, Vargas M, Iacovazzo C, Zappulo E, et al. Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn’s disease. IDCases 2019;17:e00537.
  • Vidanapathirana M, Minuvanpitiya G, Karunaratne R, Fernando A. Triple infection with disseminated tuberculosis, invasive aspergillosis and COVID-19 in an organ transplant recipient with iatrogenic immunosuppression. BMJ Case Rep 2021 Aug 10;14(8):e245131.
  • Dellière S, Angebault C, Fihman V, Foulet F, Lepeule R, Maitre B, et al. Concomitant presence of Aspergillus species and Mycobacterium species in the respiratory tract of patients: underestimated co-occurrence? Front Microbiol 2020 Jan 10;10:2980.
  • Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J 2016 Jan;47(1):45–68.
  • Hahn J, Choi JH, Chang MJ. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients. J Clin Pharm Ther 2017 Dec;42(6):661–671.
  • Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 2016 Aug 15;63(4):e1–60.
  • Geist MJP, Egerer G, Burhenne J, Riedel K-D, Mikus G. Induction of voriconazole metabolism by rifampin in a patient with acute myeloid leukemia: importance of interdisciplinary communication to prevent treatment errors with complex medications. Antimicrob Agents Chemother 2007 Sep;51(9):3455–3456.
  • Hosseini M, Shakerimoghaddam A, Ghazalibina M, Khaledi A. Aspergillus coinfection among patients with pulmonary tuberculosis in Asia and Africa countries; a systematic review and meta-analysis of cross-sectional studies. Microb Pathog 2020 Apr;141:104018.
  • Published: 2022-03-21

    Issue: 2022: Vol 9 No 3 (view)

    Section: Articles

    How to cite:
    1.
    Ahmed AO, A. Ali G, Goravey W. Concomitant Pulmonary Tuberculosis and Invasive Aspergillosis Infection in an Immunocompetent Host. EJCRIM 2022;9 doi:10.12890/2022_003249.

    Most read articles by the same author(s)